1 Zhanel GG, Hoban DI, Harding GK.The postantibi otic efet: areview of in vitro and in vivo data. Dicp, 1991, 25(2):153
2 Spivey JM. The psatiotic efet. Clin Pharm, 1992, 11(10): 865
3 Ramadan MA, Tawfik AF, Shibl AM. Post-an-tibioic efet of azithromycin and erthromyein on strepr tococal suscepibility to phagocytosis. J. Med. Micro biol, 1995, 39(1):221
4 Zhanel GG, Karlowsky JA. Davidson RJ.etal. In. fluence of human urine.on the in vito activity and postanibiotic efets of ciprofloxacin against Escherichia coli. Chemother, 1991, 37:218
5 SGortfrelssn M,Erlndsdortir H. Cudmundson A. Dileret ptters of bacterial DNA synthsis durng ritcnibiotio efet.Antimicrobe. Agent. Chemnother, 1995: 1314
6 Watanabe. T,Kanno M. Effects of macrolides on ultrastructure of staphylococcus aureus during postantibi-otic phase. Drugs. Exptl. Clin. Res, 1992,18(3):81
7 Craig WA,Ebert JG. Killing and regrowth of bac-teria in vitro: a review. Scand. J. Infect. DIs Suppl, 1990, 74:63
8 Godber LM,Walker RD, Stein-GE,et al. Phar-macokinetics,nepbrotoxicosis, and in vitro antibacterial. activity associated with single versus multiple (three times) daily gentamicin treatments in horses. Am. J. Vet. Res, 1995, 56(5):613
9 Winstanley TG, Hastings JG. Penicillin-amino-glycoside synergy and post-antibiotic effect for entero-cocci. J. Antimicrob. CHemother, 1989, 23(2): 189
10 Isaksson B, Maller R, Nilsson LE, et al. Postan-tibiotic effect of aminoglycosides on staphylococci J. An-timicrob. Che mother, 1993, 32(2):215
11 Paglia P, Molinari G, Pesce A, et al. Dactimicin, a new aminoglycoside: in vitro activity, post-antibiotic effect and ineteraction with other antibiotics. Eur. J. Clin. Microbiol. Infct. Dis, 1989, 8(7):639
12 Gudmundsson S, Einarsson S, Erlendsdottir H, et al. The post-antibiotic effect of antimicrobial combina-tions in a neutropenic murine thigh in fection model.. Antimicrob. Chemother. 1993, 31(Suppl D):177
13 Minguez F, Agra M,Luruena S, et al. Post-antibiotic effect of isepamicin compared to the as of other aminoglycosides. Drugs. Exp. Clin. Res, 1990,16(5): 231
14 Novelli A,Mazzei T, Fallani S, et al. In vitro postantibiotic effect and postantibiotic leukocyte en-hancement of tobramycin. J. Chemother, 1995, 7(4):355
15 Karlowsky JA, Zhanel GG, Davidson RJ,et al. Postantibiotic effect in pseudomonas aeruginosa fol-lowing single and multiple amino-glycoside exposures in vitro. J. Antimicrob. Chemother, 1994, 33(5):937
16 Debboa EA. Scjotp GC, Stefani s, et al. In vitro bactericidal activity and post-antibiotic effect of dactim-icin,a new aminoglycoside, alone and in com bi nation with other antibiotics. Drugs. Exp. Clin. Res, 1989, 15 (3):125
17 Gerber AU. Impact of the antibiotic dosage sched-ule on efficacy in experimental soft tissue, infec tions. Scand. J. Infect. Dis. Suppl, 1990, 74:147
18 Isaksson B, Hanberger H, Maller R, et al. The postantibiotic effect of amikacin alone and in combination with piperacillin on gram-negative bacteria. Scand. J. Infect. Dis. Suppl, 1990,74:129
19 Vogelman BS. Craig WA. Postantibiotic effects. J. Antimicrob. Chemother, 1985, 15:37
20 Zhanel GG, Craig WA. Pharmacokinetic contri-butions to postantibiotic effects. Focus on aminoglyco-sides. Clin. Pharmacokinet, 1994,27(5):377
21 Gudmundsson A. Erlendsdottir H, Gottfredsson M,et al. Impact of pH and cationic supplementation on in vitro postantibiotic effect. Antimicrob. Agents. Chemother,1991,35(12):2617
22 Park MK, Muhvich KH, Myers RA, et al. Hy-peroxia prolongs the aminoglycoside-induced postantibi-otic effect in Pse udomonas aeruginosa. Antimicrob. A-gents. Chemother, 1991, 35(4):691
23 Craig W. Pharmacodynamics of antimicrobial a-gents as a basis for determining dosage regimens. Eur. J. Clin. Microbiol. Infect. Dis, 1993, 12(Suppl 1):S6
24 Mattie H. Craig WA. Pechere JC. Determinants of efficacy and toxicity of aminoglycosides. J. Antimi-crob. Chemother, 1989, 24(3):281
25 Arai. S,Kawamura R, Kamiya H, et al.The in vivo and in vitro postantibiotic effect of aminoglycosides using a clinically isolated micro-organism. Acta. Paedi-atr. Jpn,1993. 35(1):17
26 Barclay ML, Begg EJ, Hickling KG. What is the evidence for once -daily aminoglycoside therapy Clin. Pharmacokinet,1994,27(1):32
27 Fantin B, Ebert S, Leggett J, et al. Factors af-fecting duration of in-vivo postantibiotic effect for aminoglycosides against gram-negative bacilli. J. An-timicrob. Chemother, 1991, 27(6):829
28 Bayer AS, Speert DP,Park S, et al. Functional role of mucoid exopolysaccharide (alginate) in antibiot-ic-induced and polymorphonuclear leukocyte-mediated killing of Pseudomonas aeruginosa. Infect. Immun, 1991, 59(1):302
29 Bergeron MG, Bergeron Y. Tardif M. et al. In-fluence of indomethacin on the intrarenal uptake of gen-tamicin in endotoxemic rats. Antimicrob. Agents. Chemother.1989, 33(8):1342
30 Winstanley TG, Hastings JG. Synergy between penicillin and gentamicin against enterococci. J. Antimi-crob. Chemother. 1990, 25(4):551
31 Gudmundsson S,Erlendsdottir H, Gottfredsson M,et al. The Postantibiotic effect induced by antimicro-bial combinations. Scand. J. Infect. Dis. Suppl, 1990, 74: 80
32 Gerceker AA, Otuk G. Postantibiotic effect of imipenem,alone and in combination with amikacin, on Pseudomonas aeruginosa. Chemotherapy, 1995, 41(6):433 |
